Photodynamic Therapy Using Porfimer Sodium in Treating Patients with Recurrent Mouth or Throat Dysplasia or Recurrent in situ Cancer or Stage I Cancer of the Mouth or Throat

Article

This trial will evaluate how well photodynamic therapy using porfimer sodium works in treating patients with recurrent mouth or throat dysplasia, recurrent in situ cancer of the mouth or throat, or stage I cancer of the mouth or throat.

Study Type: Interventional

Age/Sex Requirement: 18 years+ (None)

Sponsor: Roswell Park Cancer Institute

Clinicaltrials.gov Identifier: NCT00530088

Purpose: To study how well photodynamic therapy using porfimer sodium works in treating patients with recurrent mouth or throat dysplasia, recurrent in situ cancer of the mouth or throat, or stage I cancer of the mouth or throat. Primary outcomes measures include response and local toxicity.

Click here to access additional information from this third-party website.

Related Videos
Katie Ross-Driscoll, PhD, MPH | Credit: Regenstrief Institute
Video 3 -  4 KOLs are featured in, "Collaborating with Specialists: Primary Care Clinician’s Evolving Role in HE Management"
Video 3 -  4 KOLs are featured in, "HE Experts on Symptoms, Risk Factors, Diagnosis Challenges, and Severity Grading"
Shauna Applin, ARNP, an expert on HIV
© 2024 MJH Life Sciences

All rights reserved.